Skip to content

Clinical trials

Pulmonary Atelectasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Atelectasis Clear all

363 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20064
20072
20082
20092
20105
201111
20127
201311
201417
201518
201615
201726
201817
201917
202022
202120
202219
202336
202438
202536
202635

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed210
Unknown status58
Recruiting38
Not yet recruiting31
Withdrawn8
Terminated7
Active, not recruiting5
Enrolling by invitation5
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital13
Assiut University8
Cairo University6
Centre hospitalier de l'Université de Montréal (CHUM)6
Hospital Privado de Comunidad de Mar del Plata6
Istanbul University6
Region Västmanland6
Zonguldak Bulent Ecevit University4
Ain Shams University3
Ankara Etlik City Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Atelectasis363
Respiratory Distress Syndrome32
Pneumonia25
Premature Birth24
Respiratory Insufficiency24
Pneumothorax19
Hypoxia17
Postoperative Complications17
Pleural Effusion13
Respiratory Aspiration10

Trials

Showing 76 to 100 of 363. Each trial links to its page on Pharma Observatory.

263 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.